[1] |
Rennard S I, Drummond M B. Early chronic obstructive pulmonary disease: definition, assessment, and prevention[J]. Lancet, 2015,385(9979):1778-1788.
|
[2] |
Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study[J]. Lancet, 2018,391(10131):1706-1717
|
[3] |
Fermont J M, Bolton C E, Fisk M, et al. Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study[J]. PLoS One, 2020,15(2):228-234.
|
[4] |
Su Y C, Jalalvand F, Thegerstrom J, et al. The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable Haemophilus influenzae[J]. Front Immunol, 2018,9(44):25-30.
|
[5] |
冯希平. 中国居民口腔健康状况——第四次中国口腔健康流行病学调查报告[Z]. 中国陕西西安:2018.2.
|
[6] |
Shi Q, Zhang B, Xing H, et al. Patients with Chronic Obstructive Pulmonary Disease Suffer from Worse Periodontal Health-Evidence from a Meta-Analysis[J]. Front Physial, 2018,9(23):33-36.
|
[7] |
Zhou X, Wang J, Liu W, et al. Periodontal Status and Microbiologic Pathogens in Patients with Chronic Obstructive Pulmonary Disease and Periodontitis: A Case-Control Study[J]. Int J Chron Obstruct Pulmon Dis, 2020,15(12):2071-2079.
|
[8] |
Lai L, Lai Y, Wang H, et al. Diagnostic Accuracy of Procalcitonin Compared to C-Reactive Protein and Interleukin 6 in Recognizing Gram-Negative Bloodstream Infection: A Meta-Analytic Study[J]. Dis Markers, 2020,20(17):474-487.
|
[9] |
Lacoma A, Prat C, Andreo F, et al. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2011,6(11):157-169.
|
[10] |
Pantzaris N D, Spilioti D X, Psaromyalou A, et al. The Use of Serum Procalcitonin as a Diagnostic and Prognostic Biomarker in Chronic Obstructive Pulmonary Disease Exacerbations: A Literature Review Update[J]. J Clin Med Res, 2018,10(7):545-551.
|
[11] |
Wedzicha J E C, Miravitlles M, Hurst J R, et al. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline[J]. Eur Respir J, 2017,49(3):45-53.
|
[12] |
郭淑娟,刘倩,丁一. 牙周病和植体周病国际新分类简介[J]. 国际口腔医学杂志, 2019,46(02):125-134.
|
[13] |
陈亚红. 2021年GOLD慢性阻塞性肺疾病诊断、治疗及预防全球策略解读[J]. 中国医学前沿杂志(电子版), 2021,13(01):16-37.
|
[14] |
Prasanna S J. Causal relationship between periodontitis and chronic obstructive pulmonary disease[J]. J Indian Soc Periodontal, 2011,15(4):359-365.
|
[15] |
Bernasconi L, Ramenzoni L L, Al-Majid A, et al. Elevated Matrix Metalloproteinase Levels in Bronchi Infected with Periodontopathogenic Bacteria[J]. PLoS One, 2015,10(12):144-150.
|
[16] |
Tan L, Tang X, Pan C, et al. Relationship among clinical periodontal, microbiologic parameters and lung function in participants with chronic obstructive pulmonary disease[J]. J Periodontal, 2019,90(2):134-140.
|
[17] |
Wang J, Chai J, Sun L, et al. The sputum microbiome associated with different sub-types of AECOPD in a Chinese cohort[J]. BMC Infect Dis, 2020,20(1):610-616.
|
[18] |
Samsudin I, Vasikaran S D. Clinical Utility and Measurement of procalcitonin[J]. Clin Biochem Rev, 2017,38(2):59-68.
|
[19] |
Kumar N, Dayal R, Singh P, et al. A Comparative Evaluation of Presepsin with Procalcitonin and CRP in Diagnosing Neonatal Sepsis[J]. Indian J Pediatr, 2019,86(2):177-179.
|
[20] |
Gong C, Yang Y, Chen M, et al. Effect of procalcitonin on the prognosis of patients with COPD[J]. Biomed Rep, 2020,12(6):313-318.
|
[21] |
Hogea S P, Tudorache E, Fildan A P, et al. Risk factors of chronic obstructive pulmonary disease exacerbations[J]. Clin Respir J, 2020,14(3):183-197.
|
[22] |
Shen T C, Chang P Y, Lin C L, et al. Risk of Periodontal Diseases in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Population-based Cohort Study[J]. Medicine (Baltimore), 2015,94(46):20-47.
|
[23] |
Takeuchi K, Matsumoto K, Furuta M, et al. Periodontal status and lung function decline in the community: the Hisayama study[J]. Sci Rep, 2018,8(1):133-154.
|
[24] |
Titova E, Christensen A, Henriksen A H, et al. Comparison of procalcitonin, C-reactive protein, white blood cell count and clinical status in diagnosing pneumonia in patients hospitalized with acute exacerbation of COPD: A prospective observational study[J]. Chron Respir Dis, 2019,16(2):386-398.
|
[25] |
Hendek M K, Erdemir E O, Kisa U. Evaluation of salivary procalcitonin levels in different periodontal diseases[J]. J Periodontal, 2015,86(6):820-826.
|
[26] |
Yan S T, Sun L C, Jia H B, et al. Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria[J]. Am J Emerg Med, 2017,35(4):579-583.
|
[27] |
Lopes M P, Cruz A A, Xavier M T, et al. Prevotella intermedia and periodontitis are associated with severe asthma[J]. J Periodontal, 2020,91(1):46-54.
|
[28] |
Mize T W, Sundararaj K P, Leite R S, et al. Increased and correlated expression of connective tissue growth factor and transforming growth factor beta 1 in surgically removed periodontal tissues with chronic periodontitis[J]. J Periodontal Res, 2015,50(3):315-319.
|
[29] |
王悦颖,林梅,王蕾,等. 慢性牙周炎和慢性牙周炎合并慢性阻塞性肺疾病患者血清中IL-2、IL-4、IL-6、IL-10、IFN-γ及TNF-α的检测及临床意义[J]. 中国医师杂志,2017,19(8):1148-1151.
|